PASOFINO GOLD LTD (VEIN.CA) Fundamental Analysis & Valuation

TSX-V:VEIN • CA7026573054

Current stock price

0.9 CAD
+0.01 (+1.12%)
Last:

This VEIN.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. VEIN.CA Profitability Analysis

1.1 Basic Checks

  • VEIN had negative earnings in the past year.
  • In the past year VEIN has reported a negative cash flow from operations.
  • VEIN had negative earnings in each of the past 5 years.
  • VEIN had a negative operating cash flow in each of the past 5 years.
VEIN.CA Yearly Net Income VS EBIT VS OCF VS FCFVEIN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M -40M

1.2 Ratios

  • With a Return On Assets value of -80.93%, VEIN is not doing good in the industry: 71.29% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -80.93%
ROE N/A
ROIC N/A
ROA(3y)-1324.47%
ROA(5y)-1270.65%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VEIN.CA Yearly ROA, ROE, ROICVEIN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1K -1K 2K -2K -3K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for VEIN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VEIN.CA Yearly Profit, Operating, Gross MarginsVEIN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

2

2. VEIN.CA Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, VEIN has more shares outstanding
  • Compared to 5 years ago, VEIN has more shares outstanding
  • VEIN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
VEIN.CA Yearly Shares OutstandingVEIN.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
VEIN.CA Yearly Total Debt VS Total AssetsVEIN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M

2.2 Solvency

  • Based on the Altman-Z score of -10.58, we must say that VEIN is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of VEIN (-10.58) is worse than 72.78% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -10.58
ROIC/WACCN/A
WACCN/A
VEIN.CA Yearly LT Debt VS Equity VS FCFVEIN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10M -20M

2.3 Liquidity

  • VEIN has a Current Ratio of 1.24. This is a normal value and indicates that VEIN is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.24, VEIN is in line with its industry, outperforming 41.32% of the companies in the same industry.
  • VEIN has a Quick Ratio of 1.24. This is a normal value and indicates that VEIN is financially healthy and should not expect problems in meeting its short term obligations.
  • VEIN has a Quick ratio of 1.24. This is comparable to the rest of the industry: VEIN outperforms 42.95% of its industry peers.
Industry RankSector Rank
Current Ratio 1.24
Quick Ratio 1.24
VEIN.CA Yearly Current Assets VS Current LiabilitesVEIN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M

0

3. VEIN.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 69.93% over the past year.
EPS 1Y (TTM)69.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.94%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • VEIN is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -28.01% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-119.5%
EPS Next 2Y-44.83%
EPS Next 3Y-28.01%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VEIN.CA Yearly EPS VS EstimatesVEIN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 0.4

0

4. VEIN.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • VEIN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VEIN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VEIN.CA Price Earnings VS Forward Price EarningsVEIN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VEIN.CA Per share dataVEIN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.02 -0.04 -0.06 -0.08 -0.1

4.3 Compensation for Growth

  • VEIN's earnings are expected to decrease with -28.01% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-44.83%
EPS Next 3Y-28.01%

0

5. VEIN.CA Dividend Analysis

5.1 Amount

  • VEIN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

VEIN.CA Fundamentals: All Metrics, Ratios and Statistics

PASOFINO GOLD LTD

TSX-V:VEIN (4/21/2026, 7:00:00 PM)

0.9

+0.01 (+1.12%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)03-25
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners9.15%
Ins Owner ChangeN/A
Market Cap137.48M
Revenue(TTM)N/A
Net Income(TTM)-8.34M
Analysts80
Price Target2.86 (217.78%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0
BVpS-0.12
TBVpS-0.12
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -80.93%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-1324.47%
ROA(5y)-1270.65%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1284.78%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.24
Quick Ratio 1.24
Altman-Z -10.58
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)69.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.94%
EPS Next Y-119.5%
EPS Next 2Y-44.83%
EPS Next 3Y-28.01%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-53.5%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-29.69%
EBIT Next 3Y-4.2%
EBIT Next 5YN/A
FCF growth 1Y-164.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-160.57%
OCF growth 3YN/A
OCF growth 5YN/A

PASOFINO GOLD LTD / VEIN.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of PASOFINO GOLD LTD (VEIN.CA) stock?

ChartMill assigns a fundamental rating of 1 / 10 to VEIN.CA.


Can you provide the valuation status for PASOFINO GOLD LTD?

ChartMill assigns a valuation rating of 0 / 10 to PASOFINO GOLD LTD (VEIN.CA). This can be considered as Overvalued.


Can you provide the profitability details for PASOFINO GOLD LTD?

PASOFINO GOLD LTD (VEIN.CA) has a profitability rating of 0 / 10.


How financially healthy is PASOFINO GOLD LTD?

The financial health rating of PASOFINO GOLD LTD (VEIN.CA) is 2 / 10.


Can you provide the expected EPS growth for VEIN stock?

The Earnings per Share (EPS) of PASOFINO GOLD LTD (VEIN.CA) is expected to decline by -119.5% in the next year.